Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05297305 · ClinicalTrials.gov registry record · NA
Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty
A NA study, sponsored by Corewell Health East.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05297305: Clinical Trial NA study, sponsored by Corewell Health East.
NCT05297305 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05297305, a NA study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The goal of this study is to compare the effect of different ways to place the component that goes at the top of the humerus (upper arm) in reverse total shoulder replacement. Some surgeons place the humeral tray component sitting on the bone while others place it in the bone. Changing the way that the humeral component is placed may change how much the arm can raise up or turn out/in after surgery for some patients. This study compares patients with inlay humeral component (tray sits in the upper arm bone) versus onlay humeral component (tray sits on top of the upper arm bone) to see if there are differences in range of motion or function after surgery.
Primary Outcome
Range of motion of repaired shoulder, active external rotation. Measured with goniometer in degrees.
Interventions
- DEVICE Tornier Ascend Flex stem
- DEVICE Tornier Perform Stem Reverse+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2023-10-20 |
| Est. Completion | 2025-11-24 |
| Phase | NA |
Why NCT05297305 stopped before completion
NCT05297305 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Tornier Ascend Flex stem is the first listed.
NCT05297305 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05297305 about?
NCT05297305 is a clinical study titled "Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty". The goal of this study is to compare the effect of different ways to place the component that goes at the top of the humerus (upper arm) in reverse total shoulder replacement. Some surgeons place the humeral tray component sitting on the bone while others place it in the bone. Changing the way that ...
What is the current status of trial NCT05297305?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2023-10-20. Estimated completion is 2025-11-24.
What interventions are being tested in trial NCT05297305?
The interventions under investigation include: Tornier Ascend Flex stem (DEVICE), Tornier Perform Stem Reverse+ (DEVICE).
Who is sponsoring clinical trial NCT05297305?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05297305's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI